Digital Twins Gain Traction in Scientific Research
The digital twin concept is moving from theory to practice in scientific applications. Researchers at Lawrence Berkeley National Laboratory are using AI-powered digital twins to accelerate chemistry and materials science discoveries by combining real-time data with physics-based models. In a commercial example, a case study from Prescient demonstrated that digital twins of analytical instruments can improve installed base visibility by 39%.
- The global digital twin market in life sciences was estimated at USD 3.83 billion in 2024 and is projected to reach USD 17.23 billion by 2035, growing at a CAGR of 14.65%. This growth is driven by the increasing demand for predictive modeling, efficiencies in drug development, and personalized medicine. - In biomanufacturing, digital twins are being used to simulate and optimize complex processes like cell culture and fermentation by using real-time data from bioreactors. This allows for in-silico experimentation, reducing the need for costly and time-consuming physical experiments to determine optimal process parameters. - For viral vector manufacturing, a key component of cell and gene therapies, digital twins are helping to address production bottlenecks. Simulation case studies have shown the potential for a twofold increase in productivity for entities like virus-like particles, with advanced process control from a digital twin adding another 20% productivity gain. - The implementation of digital twins can significantly accelerate project timelines, with some companies reporting a 40-70% reduction in engineering and validation time. In quality control, digitally enabled labs have demonstrated the ability to cut chemical QC costs by 25-45%. - A key challenge in implementing digital twins is the integration of data from disparate systems like LIMS, MES, and ERPs to create a unified view. Standardization efforts, such as the asset administration shell (AAS) from the Industry 4.0 platform, are underway to ensure interoperability between different technologies and systems. - Digital twins enhance process validation and GMP compliance by enabling companies to justify a reduced number of Process Performance Qualification (PPQ) runs and to set robust control strategies in line with the FDA's Quality by Design initiative. They also provide a traceable, audit-ready digital record of all production data and simulations. - Beyond process optimization, digital twins are being developed for personalized medicine, where virtual models of individual patients can simulate responses to different therapies. These patient-specific models integrate genomic, imaging, and clinical data to support tailored treatment decisions. - The convergence of digital twins with AI and machine learning is creating more powerful predictive capabilities. AI algorithms analyze complex datasets from the digital twin to identify trends, predict outcomes, and optimize workflows for more precise and efficient experiments.
